Skip to main content

Table 1 Patient and disease characteristics

From: Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

Characteristic

 

Age (years) (median, range)

55 (37–62)

Gender

 Male

2 (18.2 %)

 Female

9 (81.8 %)

ECOG performance status at diagnosis

 0

7 (63.6 %)

 1

4 (36.4 %)

Primary tumor site

 Pleura

5 (45.5 %)

 Abdomen

2 (18.2 %)

 Pelvis

2 (18.2 %)

 Ovary

1 (9.1 %)

 Upper limb

1 (9.1 %)

Pathological characteristics at diagnosis

 Mitotic index (/10 HPFa) (median, range)

9 (3–30)

Necrosis

 No

6 (54.5 %)

 Yes

5 (45.5 %)

 <50 %

3

 >50 %

0

 Unknown

2

 Tumor size (mm) (median, range)

145 (45–180)

Tumor classification at diagnosis

 Benign

1 (9.1 %)

 Malignant

10 (90.9 %)

 Stage of disease at diagnosis

 

 Local

9 (81.8 %)

 Metastatic

2 (18.2 %)

  1. a/10 high-power fields